HuGE Literature Finder
Records
1
-
17
| Optimal Treatments for NSCLC Patients Harboring Primary or Acquired MET Amplification. Technology in cancer research & treatment 2022 9 21 15330338221128414. Sun Dantong, Tao Junyan, Yan Weihua, Zhu Jingjuan, Zhou Hai, Sheng Yingying, Xue Chaofan, Li Hong, Hou Hel |
| Prognostic value of soluble programmed cell death ligand-1 in patients with non-small-cell lung cancer: a meta-analysis. Immunotherapy 2022 7 14 (12): 945-956. Wang Yan, He Haiy |
| The Efficacy of Immune Checkpoint Inhibitors vs. Chemotherapy for KRAS-Mutant or EGFR-Mutant Non-Small-Cell Lung Cancers: A Meta-Analysis Based on Randomized Controlled Trials. Disease markers 2022 2022 2631852. Chen Wei, Li Ling, Cheng Sheng, Yu Junxi |
| EGFR mutation status in non-small cell lung cancer receiving PD-1/PD-L1 inhibitors and its correlation with PD-L1 expression: a meta-analysis. Cancer immunology, immunotherapy : CII 2021 Sep . Yang Huimin, Zhu Jinxiu, Xiao Rendong, Liu Yuhang, Yu Fanglin, Cai Lin, Qiu Minglian, He F |
| Influence of Sex in the Molecular Characteristics and Outcomes of Malignant Tumors. Frontiers in oncology 2021 11 752918. Araujo Jhajaira M, Rosas Gina, Belmar-López Carolina, Raez Luis E, Rolfo Christian D, Schwarz Luis J, Infante-Huaytalla Ulises, Paez Kevin J, García Luis R, Alvarado Hober, Ramos Fany P, Delgado-Espinoza Sheyla S, Cardenas-Farfan Jhon B, Cornejo Melanie, Zanabria Daniel, Colonio-Cossio Christian, Rojas-Jefferson Mario, Pinto Joseph |
| Plasma ctDNA RAS status selects patients for anti-EGFR treatment rechallenge in metastatic colorectal cancer: a meta-analysis. Experimental oncology 2021 09 43 (3): 252-256. Vlachou M S, Mauri D, Zarkavelis G, Ntellas P, Tagkas C, Gkoura S, Pentheroudakis |
| Impact of programmed death-ligand 1 expression on the patients of stage IV non-small cell lung cancer harboring epidermal growth factor receptor mutation: a systematic review and meta-analysis. Acta oncologica (Stockholm, Sweden) 2020 Aug 1-8. Lee Chia Ching, Soon Yu Yang, Leong Cheng Nang, Koh Wee Yao, Tey Jere |
| Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis. Cancers 2019 Aug 11 (9): . Buonerba Carlo, Iaccarino Simona, Dolce Pasquale, Pagliuca Martina, Izzo Michela, Scafuri Luca, Costabile Ferdinando, Riccio Vittorio, Ribera Dario, Mucci Brigitta, Carrano Simone, Picozzi Fernanda, Bosso Davide, Formisano Luigi, Bianco Roberto, De Placido Sabino, Di Lorenzo Giusep |
| PD-L1 expression and its effect on clinical outcomes of EGFR-mutant NSCLC patients treated with EGFR-TKIs. Cancer biology & medicine 2018 Nov 15 (4): 434-442. Bai Yuchen, Chen Xiaoxia, Hou Likun, Qian Jun, Jiang Tao, Zhou Caicun, Ciebiada Maci |
| Clinical and Molecular Predictors of PD-L1 Expression in Non-Small-Cell Lung Cancer: Systematic Review and Meta-analysis. Clinical lung cancer 2018 Feb . Petrelli Fausto, Maltese Mariangela, Tomasello Gianluca, Conti Barbara, Borgonovo Karen, Cabiddu Mary, Ghilardi Mara, Ghidini Michele, Passalacqua Rodolfo, Barni Sandro, Brighenti Matt |
| Impact of PD-L1 expression, driver mutations and clinical characteristics on survival after anti-PD-1/PD-L1 immunotherapy versus chemotherapy in non-small-cell lung cancer: A meta-analysis of randomized trials. Oncoimmunology 2018 12 7 (12): e1396403. Huang Qingyuan, Zhang Hua, Hai Josephine, Socinski Mark A, Lim Eric, Chen Haiquan, Stebbing Just |
| A systematic and genome-wide correlation meta-analysis of PD-L1 expression and targetable NSCLC driver genes. Journal of thoracic disease 2017 Aug 9 (8): 2560-2571. Li Jin, Chen Yaoqi, Shi Xiaoshun, Le Xiaobing, Feng Fenglan, Chen Jingyi, Zhou Chengzhi, Chen Yusong, Wen Shuai, Zeng Haikang, Chen Allen M, Zhang |
| Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR-Mutated Non-Small Cell Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Dec . Ding Pei Ni, Lord Sarah J, Gebski Val, Links Matthew, Bray Victoria, Gralla Richard J, Yang James Chih-Hsin, Lee Chee Kho |
| Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 May 22 (5): 827-34. Park Jong Y, Amankwah Ernest K, Anic Gabriella M, Lin Hui-Yi, Walls Brooke, Park Hyun, Krebs Kevin, Madden Melissa, Maddox Kristen, Marzban Suroosh, Fang Shenying, Chen Wei, Lee Jeffrey E, Wei Qingyi, Amos Christopher I, Messina Jane L, Sondak Vernon K, Sellers Thomas A, Egan Kathleen |
| The prognostic role of BRAF mutation in metastatic colorectal cancer receiving anti-EGFR monoclonal antibodies: a meta-analysis. PloS one 2013 8 (6): e65995. Yuan Zi-Xu, Wang Xiao-Yan, Qin Qi-Yuan, Chen De-Feng, Zhong Qing-Hua, Wang Lei, Wang Jian-Pi |
| Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis. Ontario health technology assessment series 2010 (23): 1-57. Authors are not available |
| Epidermal growth factor receptor gene amplification as a prognostic marker in glioblastoma multiforme: results of a meta-analysis. Oncology research 2001 1 12 (2): 107-12. Huncharek M, Kupelnick |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: